|MAAT PHARMA||Research Director INRA & Scientific Advisor||France|
| How are current advances in microbiome analysis bringing combined solutions opportunities to the food industry? |
Joël is Research Director at INRA Micalis Institute “Food and Gut Microbiology for Human Health” (www.micalis.fr) and Scientific Director of MetaGenoPolis (www.mgps.eu), a pre-industrial demonstrator in quantitative and functional metagenomics of the national “Futures Investment” program. Gut microbial ecologist by training, Joel pioneered intestinal metagenomics towards food-microbe-host interactions as well as diagnostic applications. With > 30 years of academic research and > 220 publications, Joël aims to provide a better understanding of man-microbes symbiosis towards personalized preventive nutrition and precision medicine. Joel is co-founder and scientific advisor of www.maat-pharma.com, a startup company dedicated to provide safe and standardized microbiotherapy solutions for the reconstruction of host-microbes symbiosis in the context of programmed clinical interventions inducing dysbiosis. He chairs the www.gutmicrobiotaforhealth.com scientific web-platform.